儿童川崎病心血管并发症的发病机制、诊断与临床管理研究进展
Research Progress on the Pathogenesis, Diagnosis and Clinical Management of Cardiovascular Complications in Children with Kawasaki Disease
摘要: 川崎病是一种急性系统性血管炎综合征,其病因及发病机制尚不明确,好发于5岁以下婴幼儿,现已成为全球导致儿童后天性心脏病最常见的病因之一。心血管系统是川崎病最主要的受累靶器官,并发症主要包括冠状动脉扩张、冠状动脉瘤、心肌炎、心包炎、心功能不全及瓣膜损害等,其中冠状动脉病变是造成患儿急性期死亡及远期心血管不良事件的最主要原因。近些年来,临床诊疗水平的逐渐提升与影像学技术的不断发展,川崎病心血管并发症的早期识别、危险分层与综合管理策略不断更新。本文就儿童川崎病心血管并发症的流行病学特征、发病机制、诊断评估方法、急性期与远期治疗管理、预后及研究展望等方面进行系统综述,为临床医师提供规范化、精准化的诊疗参考,进一步改善川崎病患儿的长期预后。
Abstract: Kawasaki disease (KD) is an acute systemic vasculitis syndrome with an incompletely clarified etiology, which is more common in infants and young children under 5 years old. Its incidence is on the rise globally, and it has become one of the most common causes of acquired heart disease in children worldwide. The cardiovascular system is the main target organ involved in Kawasaki disease, with a wide spectrum of complications, mainly including coronary artery dilatation, coronary artery aneurysm, myocarditis, pericarditis, cardiac insufficiency, and cardiac valve damage. Among them, coronary artery lesions (CALs) are the core cause of acute death and long-term adverse cardiovascular events in children, and also the key and difficult point in clinical diagnosis, treatment and long-term management. In recent years, with the continuous improvement of clinical diagnosis and treatment level and the iterative development of imaging evaluation technologies (such as high-resolution echocardiography, coronary computed tomography angiography, cardiac magnetic resonance imaging, etc.), the accuracy of early identification, the refinement of risk stratification and the comprehensive management strategies of cardiovascular complications of Kawasaki disease have been significantly optimized. Based on the latest domestic and foreign research progress, this article systematically reviews the epidemiological characteristics, pathogenesis, diagnostic and evaluation methods, acute and long-term treatment and management, prognosis and research prospects of cardiovascular complications of Kawasaki disease in children, aiming to provide standardized and precise diagnosis and treatment ideas and reference basis for clinicians, further optimize the diagnosis and treatment process, and improve the long-term cardiovascular prognosis of children with Kawasaki disease.
文章引用:刘佳. 儿童川崎病心血管并发症的发病机制、诊断与临床管理研究进展[J]. 临床个性化医学, 2026, 5(2): 354-364. https://doi.org/10.12677/jcpm.2026.52135

参考文献

[1] Goel, A.R. and Yalcindag, A. (2025) An Update on Kawasaki Disease. Current Rheumatology Reports, 27, Article No. 4. [Google Scholar] [CrossRef] [PubMed]
[2] Jone, P., Tremoulet, A., Choueiter, N., Dominguez, S.R., Harahsheh, A.S., Mitani, Y., et al. (2024) Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement from the American Heart Association. Circulation, 150, e70267. [Google Scholar] [CrossRef] [PubMed]
[3] Nakamura, Y., Yashiro, M. and Yanagawa, H. (2025) Epidemiology of Kawasaki Disease in Japan in 2021-2022: Results of the 27th Nationwide Survey. Pediatrics International, 67, e70007. [Google Scholar] [CrossRef] [PubMed]
[4] Suzuki, A., Kamiya, T., Kuwahara, N., Ono, Y., Kohata, T., Takahashi, O., et al. (1986) Coronary Arterial Lesions of Kawasaki Disease: Cardiac Catheterization Findings of 1100 Cases. Pediatric Cardiology, 7, 3-9. [Google Scholar] [CrossRef] [PubMed]
[5] Jone, P., Tremoulet, A., Choueiter, N., Dominguez, S.R., Harahsheh, A.S., Mitani, Y., et al. (2025) Correction to: Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement from the American Heart Association. Circulation, 151, e863.
[6] Uehara, R. and Belay, E.D. (2012) Epidemiology of Kawasaki Disease in Asia, Europe, and the United States. Journal of Epidemiology, 22, 79-85. [Google Scholar] [CrossRef] [PubMed]
[7] Newburger, J.W., Sleeper, L.A., McCrindle, B.W., Minich, L.L., Gersony, W., Vetter, V.L., et al. (2007) Randomized Trial of Pulsed Corticosteroid Therapy for Primary Treatment of Kawasaki Disease. New England Journal of Medicine, 356, 663-675. [Google Scholar] [CrossRef] [PubMed]
[8] 黄玉娟, 李夙凌, 田园, 等. 中国儿童川崎病诊疗循证指南(2023年) [J]. 中国当代儿科杂志, 2023, 25(12): 1198-1210.
[9] McCrindle, B.W., Rowley, A.H., Newburger, J.W., et al. (2017) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation, 135, e927-e999.
[10] McCrindle, B.W. (2009) Kawasaki Disease: A Childhood Disease with Important Consequences into Adulthood. Circulation, 120, 6-8. [Google Scholar] [CrossRef] [PubMed]
[11] Lin, M. and Wu, M. (2018) The Global Epidemiology of Kawasaki Disease: Review and Future Perspectives. Global Cardiology Science and Practice, 2017, 1-6. [Google Scholar] [CrossRef] [PubMed]
[12] Singh, S., Vignesh, P. and Burgner, D. (2015) The Epidemiology of Kawasaki Disease: A Global Update. Archives of Disease in Childhood, 100, 1084-1088. [Google Scholar] [CrossRef] [PubMed]
[13] Watelle, L., Dahoud, A., Blais, S., Scuccimarri, R., Renaud, C., McCrindle, B.W., et al. (2025) Males with Kawasaki Disease Develop Coronary Artery Aneurysms More than Twice as Much as Females. Paediatrics & Child Health, 30, 250-256. [Google Scholar] [CrossRef] [PubMed]
[14] Ramphul, K. and Mejias, S.G. (2018) Kawasaki Disease: A Comprehensive Review. Archives of Medical ScienceAtherosclerotic Diseases, 3, 41-45. [Google Scholar] [CrossRef] [PubMed]
[15] Li, T., Feng, J., Li, N. and Liu, T. (2021) Correct Identification of Incomplete Kawasaki Disease. Journal of International Medical Research, 49, Article ID: 1001712. [Google Scholar] [CrossRef] [PubMed]
[16] Shafy, S.S.M., Salavarria, K.A.C., Saleh, S., Cuino, I., Nadeem, S., Perez, R.C.R., et al. (2025) Long-Term Outcomes of Coronary Artery Aneurysms in Children with Kawasaki Disease: A Systematic Review. Cureus, 17, e94418. [Google Scholar] [CrossRef
[17] Libby, P., Ridker, P.M. and Hansson, G.K. (2009) Inflammation in Atherosclerosis. Journal of the American College of Cardiology, 54, 2129-2138. [Google Scholar] [CrossRef] [PubMed]
[18] Yoshikane, Y., Koga, M., Cho, T., Imanaka-Yoshida, K., Yamamoto, Y., Hashimoto, J., et al. (2016) Tissue Remodeling in Vascular Wall in Kawasaki Disease-Related Vasculitis Model Mice. In: Nakanishi, T., Markwald, R., Baldwin, H., Keller, B., Srivastava, D. and Yamagishi, H., Eds., Etiology and Morphogenesis of Congenital Heart Disease, Springer, 241-242. [Google Scholar] [CrossRef
[19] Jia, C., Zhang, J., Chen, H., Zhuge, Y., Chen, H., Qian, F., et al. (2019) Endothelial Cell Pyroptosis Plays an Important Role in Kawasaki Disease via HMGB1/RAGE/Cathespin B Signaling Pathway and NLRP3 Inflammasome Activation. Cell Death & Disease, 10, Article No. 778. [Google Scholar] [CrossRef] [PubMed]
[20] Hara, T. and Sakai, Y. (2025) The Etiopathogenesis of Kawasaki Disease: Evolving Understanding of Diverse Triggers. Immunity, Inflammation and Disease, 13, e70267. [Google Scholar] [CrossRef
[21] Paolini, L., Guida, F., Calvaruso, A., Andreozzi, L., Pierantoni, L., Lanari, M., et al. (2024) Endothelial Dysfunction: Molecular Mechanisms and Therapeutic Strategies in Kawasaki Disease. International Journal of Molecular Sciences, 25, Article 13322. [Google Scholar] [CrossRef] [PubMed]
[22] Kumrah, R., Goyal, T., Rawat, A. and Singh, S. (2024) Markers of Endothelial Dysfunction in Kawasaki Disease: An Update. Clinical Reviews in Allergy & Immunology, 66, 99-111. [Google Scholar] [CrossRef] [PubMed]
[23] Qian, G., Wang, Y., Yao, H., Zhang, Z., Wang, W., Xu, L., et al. (2025) Involvement of USP7 in Aggravating Kawasaki Disease by Promoting TGFβ2 Signaling Mediated Endothelial-Mesenchymal Transition and Coronary Artery Remodeling. International Immunopharmacology, 146, Article ID: 113823. [Google Scholar] [CrossRef] [PubMed]
[24] Patra, P.K., Banday, A.Z., Das, R.R., Manohari, S., Jindal, A.K. and Singh, S. (2023) Long-Term Vascular Dysfunction in Kawasaki Disease: Systematic Review and Meta-Analyses. Cardiology in the Young, 33, 1614-1626. [Google Scholar] [CrossRef] [PubMed]
[25] Onouchi, Y., Gunji, T., Burns, J.C., Shimizu, C., Newburger, J.W., Yashiro, M., et al. (2008) ITPKC Functional Polymorphism Associated with Kawasaki Disease Susceptibility and Formation of Coronary Artery Aneurysms. Nature Genetics, 40, 35-42. [Google Scholar] [CrossRef] [PubMed]
[26] Khor, C.C., Davila, S., Breunis, W.B., Lee, Y., Shimizu, C., Wright, V.J., et al. (2011) Genome-Wide Association Study Identifies FCGR2A as a Susceptibility Locus for Kawasaki Disease. Nature Genetics, 43, 1241-1246. [Google Scholar] [CrossRef] [PubMed]
[27] Uehara, R., Yashiro, M., Nakamura, Y. and Yanagawa, H. (2003) Kawasaki Disease in Parents and Children. Acta Paediatrica, 92, 694-697. [Google Scholar] [CrossRef
[28] Dou, J. (2024) Relationship between Serum Plasminogen Activator and D-Dimer Levels and the Severity of Kawasaki Disease in Children as Well as Their Predictive Value for Coronary Artery Lesion. American Journal of Translational Research, 16, 3240-3247. [Google Scholar] [CrossRef] [PubMed]
[29] Wang, W., Zhu, L., Li, X., Liu, Z., Lv, H. and Qian, G. (2023) Emerging Evidence of Microbial Infection in Causing Systematic Immune Vasculitis in Kawasaki Disease. Frontiers in Microbiology, 14, Article 1313838. [Google Scholar] [CrossRef] [PubMed]
[30] Kobayashi, T., Ayusawa, M., Suzuki, H., Abe, J., Ito, S., Kato, T., et al. (2020) Revision of Diagnostic Guidelines for Kawasaki Disease (6th Revised Edition). Pediatrics International, 62, 1135-1138. [Google Scholar] [CrossRef] [PubMed]
[31] Yang, H., Du, Z. and Fu, P. (2013) Clinical Features of Recurrent Kawasaki Disease and Its Risk Factors. European Journal of Pediatrics, 172, 1641-1647. [Google Scholar] [CrossRef] [PubMed]
[32] Niu, L., An, X.J., Fu, M.Y., He, X.H. and Wang, Q.W. (2015) Observation of Kawasaki Disease-Related Indexes and the Study of Relationship between Myocardial Enzyme Changes and Coronary Artery Lesions. European Review for Medical and Pharmacological Sciences, 19, 4407-4410.
[33] Mossberg, M., Mohammad, A.J., Kahn, F., Segelmark, M. and Kahn, R. (2021) High Risk of Coronary Artery Aneurysm in Kawasaki Disease. Rheumatology, 60, 1910-1914. [Google Scholar] [CrossRef] [PubMed]
[34] Patel, R.M. and Shulman, S.T. (2015) Kawasaki Disease: A Comprehensive Review of Treatment Options. Journal of Clinical Pharmacy and Therapeutics, 40, 620-625. [Google Scholar] [CrossRef] [PubMed]
[35] Conte, C., Sogni, F., Rigante, D. and Esposito, S. (2023) An Update on Reports of Atypical Presentations of Kawasaki Disease and the Recognition of IVIG Non-Responder Children. Diagnostics, 13, Article 1441. [Google Scholar] [CrossRef] [PubMed]
[36] 穆志龙, 焦富勇, 谢凯生.《川崎病心血管后遗症的诊断和管理指南(JCS/JSCS 2020)》解读[J]. 中国当代儿科杂志, 2021, 23(3): 213-220.
[37] Maccora, I., Calabri, G.B., Favilli, S., Brambilla, A., Trapani, S., Marrani, E., et al. (2021) Long-Term Follow-Up of Coronary Artery Lesions in Children in Kawasaki Syndrome. European Journal of Pediatrics, 180, 271-275. [Google Scholar] [CrossRef] [PubMed]
[38] Liu, Y., Zhang, Y., Xie, Y., Li, W., Wei, H., Liu, L., et al. (2025) Risk Factors and Regression of Coronary Aneurysms in Infants with Kawasaki Disease. Cardiovascular Therapeutics, 2025, Article ID: 9988778. [Google Scholar] [CrossRef
[39] Kato, T., Miura, M., Kobayashi, T., et al. (2023) Analysis of Coronary Arterial Aneurysm Regression in Patients with Kawasaki Disease by Aneurysm Severity: Factors Associated With Regression. Journal of the American Heart Association, 12, e022417.
[40] Chen, Y., Yang, M., Zhang, M., Wang, H., Zheng, Y., Sun, R., et al. (2025) Single-cell Transcriptome Reveals Potential Mechanisms for Coronary Artery Lesions in Kawasaki Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 44, 866-882. [Google Scholar] [CrossRef] [PubMed]
[41] Wang, S., Luo, G., Ji, Z. and Pan, S. (2025) No Causal Association between Gut Microbiota and Kawasaki Disease: A Two-Sample Mendelian Randomization Study. Pediatric Research, 98, 423-430. [Google Scholar] [CrossRef] [PubMed]
[42] Jena, P.K., Arditi, M. and Noval Rivas, M. (2025) Gut Microbiota Alterations in Patients with Kawasaki Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 45, 345-358. [Google Scholar] [CrossRef] [PubMed]
[43] Ferrara, G., Giani, T., Caparello, M.C., Farella, C., Gamalero, L. and Cimaz, R. (2020) Anakinra for Treatment-Resistant Kawasaki Disease: Evidence from a Literature Review. Pediatric Drugs, 22, 645-652. [Google Scholar] [CrossRef] [PubMed]
[44] Zeng, Y., Zhang, M., Ko, S. and Chen, F. (2021) An Update on Cardiovascular Risk Factors after Kawasaki Disease. Frontiers in Cardiovascular Medicine, 8, Article 671198. [Google Scholar] [CrossRef] [PubMed]
[45] Hara, T., Nakashima, Y., Sakai, Y., Nishio, H., Motomura, Y. and Yamasaki, S. (2016) Kawasaki Disease: A Matter of Innate Immunity. Clinical and Experimental Immunology, 186, 134-143. [Google Scholar] [CrossRef] [PubMed]